Tumour-associated macrophages targeted transfection with NF-κB decoy/mannose-modified bubble lipoplexes inhibits tumour growth in tumour-bearing mice

Journal of Drug Targeting

Volumn 22, Issue 5, 2014, Pages 439-449

  Kono, Yusuke ^a   Kawakami, Shigeru ^b   Higuchi, Yuriko ^a   Maruyama, Kazuo ^c   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a,d  

^a KYOTO UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Cancer therapy; Oligonucleotides; Phenotype; Sonoporation

Indexed keywords

ARGINASE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPLEX; MANNOSE MODIFIED BUBBLE LIPOPLEX; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; DRUG CARRIER; LIPOSOME; MACROGOL DERIVATIVE; MANNOSE; NF-KAPPAB DECOY; OLIGODEOXYRIBONUCLEOTIDE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CHEMISTRY; COLONIC NEOPLASMS; GENE TRANSFER; GENETICS; IMMUNOLOGY; MACROPHAGE; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL; ULTRASOUND;

ANIMALS; COLONIC NEOPLASMS; DRUG CARRIERS; FEMALE; GENE TRANSFER TECHNIQUES; LIPOSOMES; MACROPHAGES; MANNOSE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; OLIGODEOXYRIBONUCLEOTIDES; POLYETHYLENE GLYCOLS; REAL-TIME POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TRANSFECTION; ULTRASONICS;

EID: 84901013905     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2014.880443     Document Type: Article

References (46)

1. Lee HW, Choi HJ, Ha SJ, et al. Recruitment of monocytes/ macrophages in different tumor microenvironments. Biochim Biophys Acta 2013;1835:170-9
2. Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol 2012;33:119-26
3. Mantovani A, Schioppa T, Porta C, et al. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 2006;25:315-22
4. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71-8
5. Siveen KS, Kuttan G. Role of macrophages in tumour progression. Immunol Lett 2009;123:97-102
6. Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. Scientific World Journal 2011;11:2391-402
7. Mosser DM. The many faces of macrophages activation. J Leukoc Biol 2003;73:209-12
8. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35
9. Sica A, Schioppa T, Mantovni A, Allavena P. Tumour-associatedmacrophages are a distinct M2 polarised population promotingb tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006;42:717-27
10. Coscia M, Quaglino E, Iezzi M, et al. Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. J Cell Mol Med 2010; 14:2803-15
11. Hagemann T, Lawrence T, McNeish I, et al. ''Re-educating'' tumor-associated macrophages by targeting NF-kB. J Exp Med 2008;205:1261-8
12. Nakanishi Y, Nakatsuji M, Seno H, et al. COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps. Carcinogenesis 2011;32:1333-9
13. Biswas SK, Lewis CE. NF-kB as a central regulator of macrophage function in tumors. J Leukoc Biol 2010;88:877-84
14. Mancino A, Lawrence T. Nuclear factor-kB and tumor-associated macrophages. Clin Cancer Res 2010;16:784-9
15. Porta C, Rimoldi M, Raes G, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kB. Proc Natl Acad Sci USA 2009;106: 14978-83
16. Saccani A, Schioppa T, Porta T, et al. p50 nuclear factor-kB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 2006;66:11432-40
17. Morishita R, Tomita N, Kaneda Y, Ogihara T. Molecular therapy to inhibit NFkB activation by transcription factor decoy oligonucleotides. Curr Opin Pharmacol 2004;4:139-46
18. Wijagkanalan W, Kawakami S, Higuchi Y, et al. Intracheally instilled mannosylated cationic liposome/NFkB decoy complexes for effective prevention of LPS-induced lung inflammation. J Control Release 2011;149:42-50
19. Cieslewicz M, Tang J, Yu JL, et al. Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival. Proc Natl Acad Sci USA 2013;110:15919-24
20. Huang Z, Zhang Z, Jiang Y, et al. Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy. J Control Release 2012;158:286-92
21. Zhu S, Niu M, O'Mary H, Cui Z. Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. Mol Pharm 2013;10:3525-30
22. Un K, Kawakami S, Yoshida M, et al. Efficient suppression of murine intracellular adhesion molecule-1 using ultrasoundresponsive and mannose-modified lipoplexes inhibits acute hepatic inflammation. Hepatology 2012;56:259-69
23. Allavena P, Chieppa M, Bianchi G, et al. Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages. Clin Dev Immunol 2010;2010:547179
24. Hagemann T, Wilson J, Burke F, et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol 2006;176:5023-32
25. Un K, Kawakami S, Suzuki R, et al. Development of ultrasoundresponsive and mannose-modified gene carrier for DNA vaccine therapy. Biomaterials 2010;31:7813-26
26. De Stefano D Oligonucleotides decoy to NF-kappaB: becoming a reality? Discov Med 2011 12 97-105
27. Egashira K, Suzuki J, Ito H, et al. Long-term follow up of initial clinical cases with NF-kB decoy oligodeoxynucleotide transfection at the site of coronary stenting. J Gene Med 2008;10:805-9
28. Suzuki J, Tezuka D, Morishita R, Isobe M. An initial case of suppressed restenosis with nuclear factor-kappa B decoy transfection after percutaneous coronary intervention. J Gene Med 2009;11: 89-91
29. Higuchi Y, Nishikawa M, Kawakami S, et al. Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells. Int J Pharm 2004;287:147-54
30. Dinh TD, Higuchi Y, Kawakami S, et al. Evaluation of osteoclastogenesis via NFkB decoy/mannosylated cationic liposome-mediated inhibition of pro-inflammatory cytokine production from primary cultured macrophages. Pharm Res 2011;28: 742-51
31. Hattori Y, Kawakami S, Nakamura K, et al. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route. J pharmacol Exp Ther 2006;318:828-34
32. Kawakami S, Sato A, Nishikawa M, et al. Mannose receptormediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther 2000;7:292-9
33. Lu CT, Zhao YZ, Wu Y, et al. Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles. Cancer Chemother Pharmacol 2011;68:343-8
34. Suzuki R, Namai E, Oda Y, et al. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles tumoral ultrasound exposure. J Control Release 2010;142:245-50
35. Zhao YZ, Lu CT, Zhou ZC, et al. Enhancing chemotherapeutic drug inhibition on tumor growth by ultrasound: an in vivo experiment. J Drug Target 2011;19:154-60
36. Suzuki R, Takizawa T, Negishi Y, et al. Effective gene delivery with liposomal bubbles and ultrasound as novel non-viral system. J Drug Target 2007;15:531-7
37. Un K, Kawakami S, Suzuki R, et al. Enhanced transfection efficiency into macrophages and dendritic cells by a combination method using mannosylated lipoplexes and bubble liposomes with ultrasound exposure. Hum Gene Ther 2010;21:65-74
38. Un K, Kawakami S, Yoshida M, et al. The elucidation of gene transferring mechanism by ultrasound-responsive and unmodified and mannose-modified lipoplexes. Biomaterials 2011;32: 4659-69
39. Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002;23:579-55
40. Massi D, Marconi C, Franchi A, et al. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors. Hum Pathol 2007; 38:1516-25
41. Pettersen JS, Fuentes-Duculan J, Suárez-Fariñas M, et al. Tumorassociated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. J Invest Dermatol 2011;131: 1322-30
42. Wu H, Xu JB, He YL, et al. Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. J Surg Oncol 2012;106:462-8
43. Kawamura I, Morishita R, Tomita N, et al. Intratumoral injection of oligonucleotides to the NFkB binding site inhibits cachexia in a mouse tumor model. Gene Ther 1999;6:91-7
44. Kono Y, Kawakami S, Higuchi Y, et al. In vitro evaluation of inhibitory effect of NF-kB activity by siRNA on protumor characteristics of M2-like macrophages. Biol Pharm Bull 2014;37:137-44
45. Un K, Kawakami S, Higuchi Y, et al. Involvement of activated transcriptional process in efficient gene transfection using unmodified and mannose-modified bubble lipoplexes with ultrasound exposure. J Control Release 2011;156: 355-63
46. Un K, Kawakami S, Suzuki R, et al. Suppression of melanoma growth and metastasis by DNA vaccination using an ultrasoundresponsive and mannose-modified gene carrier. Mol Pharm 2011;8: 543-54